We are live on ! Find out more
Nisa Investment Advisors

Nisa Investment Advisors Portfolio holdings

AUM $32B
1-Year Est. Return 32.86%
This Fund
S&P 500
This Quarter Est. Return
+3.64%
1 Year Est. Return
+32.86%
3 Year Est. Return
+108.44%
5 Year Est. Return
+138.89%
10 Year Est. Return
+505.54%
AUM
$30.3B
AUM Growth
+$4.38B
Cap. Flow
+$3.73B
Cap. Flow %
12.33%
Top 10 Hldgs %
58.9%
Holding
3,119
New
137
Increased
1,028
Reduced
1,285
Closed
158

Top Sells

Rank Stock Value
1
HON icon
Honeywell
HON
+$68.3M
2
JNJ icon
Johnson & Johnson
JNJ
+$57M
3
COST icon
Costco
COST
+$47.9M
4
MS icon
Morgan Stanley
MS
+$38.8M
5
MSFT icon
Microsoft
MSFT
+$29.2M

Sector Composition

Rank Sector Weight
1 Technology 19.76%
2 Financials 8.66%
3 Communication Services 6.83%
4 Healthcare 5.94%
5 Consumer Discretionary 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HE icon
1801
Hawaiian Electric Industries
HE
$2.05B
$29.2K ﹤0.01%
2,376
+31
+1% +$359
BKD icon
1802
Brookdale Senior Living
BKD
$3.04B
$29.1K ﹤0.01%
2,696
-408
-13% -$4.01K
HRMY icon
1803
Harmony Biosciences
HRMY
$2.22B
$28.9K ﹤0.01%
773
+256
+50% +$8.42K
STC icon
1804
Stewart Information Services
STC
$2.07B
$28.9K ﹤0.01%
411
-66
-14% -$4.75K
EWTX icon
1805
Edgewise Therapeutics
EWTX
$4.72B
$28.8K ﹤0.01%
1,162
+288
+33% +$5.78K
WSBC icon
1806
WesBanco
WSBC
$4.1B
$28.7K ﹤0.01%
853
SBSW icon
1807
Sibanye-Stillwater
SBSW
$7.61B
$28.5K ﹤0.01%
2,000
TRUP icon
1808
Trupanion
TRUP
$1.34B
$28.3K ﹤0.01%
758
-352
-32% -$13.8K
FHTX icon
1809
Foghorn Therapeutics
FHTX
$367M
$28.3K ﹤0.01%
5,238
RELY icon
1810
Remitly
RELY
$5.5B
$28.2K ﹤0.01%
2,045
+147
+8% +$2.14K
VERA icon
1811
Vera Therapeutics
VERA
$2.29B
$28.2K ﹤0.01%
557
-93
-14% -$3.3K
AMBA icon
1812
Ambarella
AMBA
$3.58B
$28.2K ﹤0.01%
398
CMPX icon
1813
Compass Therapeutics
CMPX
$405M
$28.2K ﹤0.01%
5,248
GRAL
1814
GRAIL Inc
GRAL
$3.04B
$28.2K ﹤0.01%
329
-23
-7% -$1.99K
UFPT icon
1815
UFP Technologies
UFPT
$2.51B
$28K ﹤0.01%
126
+6
+5% +$1.29K
ACLX
1816
DELISTED
Arcellx
ACLX
$28K ﹤0.01%
429
-96
-18% -$7.66K
RCUS icon
1817
Arcus Biosciences
RCUS
$3.65B
$27.9K ﹤0.01%
1,172
+72
+7% +$1.47K
ALHC icon
1818
Alignment Healthcare
ALHC
$2.91B
$27.5K ﹤0.01%
1,394
AUPH icon
1819
Aurinia Pharmaceuticals
AUPH
$2.04B
$27.5K ﹤0.01%
1,726
-498
-22% -$7.06K
STRA icon
1820
Strategic Education
STRA
$1.84B
$27.5K ﹤0.01%
343
+12
+4% +$958
LXEO icon
1821
Lexeo Therapeutics
LXEO
$394M
$27.5K ﹤0.01%
2,765
AORT icon
1822
Artivion
AORT
$1.4B
$27.4K ﹤0.01%
601
-62
-9% -$2.76K
PEN icon
1823
Penumbra
PEN
$12.9B
$27.4K ﹤0.01%
88
CXW icon
1824
CoreCivic
CXW
$3.2B
$27.3K ﹤0.01%
1,429
-305
-18% -$5.59K
SLDB icon
1825
Solid Biosciences
SLDB
$973M
$27.3K ﹤0.01%
4,836
-55,700
-92% -$302K

Similar funds

Nisa Investment Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Nisa Investment Advisors held 3,119 positions worth $30.3B, up 17% from $25.9B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Nisa Investment Advisors deployed $3.73B of net new capital in Q4 2025, opening 137 new positions and adding to 1,028 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 1,318,017 shares worth $87M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Honeywell, an estimated $68.3M trimmed.

  • Nisa Investment Advisors's largest Q4 2025 buy was iShares Core S&P Mid-Cap ETF: 1,318,017 shares worth $87M.
  • Nisa Investment Advisors added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $3.3B increase.
  • Nisa Investment Advisors's biggest Q4 2025 reduction was Honeywell, cutting an estimated $68.3M.
  • Nisa Investment Advisors fully exited Interpublic Group of Companies in Q4 2025, selling an estimated $4.13M.
  • Nisa Investment Advisors's ten largest holdings make up 59% of its $30.3B portfolio in Q4 2025.
  • Nisa Investment Advisors opened 137 new positions and closed 158 in Q4 2025.
  • Nisa Investment Advisors's portfolio value rose 17% quarter-over-quarter to $30.3B.

Based on Nisa Investment Advisors's 13F filing for Q4 2025, filed 15 Jan 2026.